Monday, December 23

GenEdit Collaborates with Genentech for Non-Viral Nanoparticle Development

GenEdit Joins Forces with Genentech for Non-Viral Nanoparticle Development

Main Ideas:

  • GenEdit has announced a collaboration with Genentech to develop non-viral, non-lipid, hydrophilic nanoparticles (HNPs) using its NanoGalaxy® platform.
  • The NanoGalaxy platform consists of a library of thousands of unique nanoparticles created by combining hydrophilic polymers with small-molecule side chains.

Author’s Take:

GenEdit’s collaboration with Genentech to develop non-viral nanoparticles using the NanoGalaxy platform aims to address the delivery challenges in gene editing. The use of hydrophilic polymers and small-molecule side chains in creating targeted nanoparticles has the potential to revolutionize gene therapy. This collaboration showcases the importance of collaboration in advancing the field of biotechnology and genetic engineering.


Click here for the original article.